Clinical and Translational Oncology10.1007/s12094-014-1247-x2014173173-179Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristicsJ. Fang, Q. Xu,,
Clinical and Experimental Otorhinolaryngology10.21053/ceo.2018.00171201912127-32Clinical Characteristics of Temporal Bone MetastasesKunho Song, Ki-Wan Park, Jae-Hyung Heo, Ik-Chan Song, Yong-Ho Park, Jin Woong Choi,,
Bone Cancer10.1016/b978-0-12-416721-6.00058-32015685-689Bone metastases, clinical trials II: zoledronic acid and denosumab in the prevention of bone metastasesMichael Gnant,
10.21203/rs.2.18443/v12019Clinical characteristics and prognosis of renal cell carcinoma with spinal bone metastasesJianpo Zhai, Ning Liu, Hai Wang, Haidong Wang, Guanglin Huang, Libo Man,
Bone10.1016/8756-3282(91)90058-q199112S7Clinical consequences of osteolytic bone metastasesM. Namer,
International Journal of Clinical Practice10.1111/j.1368-5031.2005.00627.x200559111366-1367Bone metastases as a cause of hypocalcaemiaI. Talapatra, D. J. Tymms,
Cancer Metastasis – Biology and Treatment10.1007/978-1-4020-9819-2_2200931-50Pathophysiology of Bone MetastasesG. David. Roodman
Cancer Metastasis - Biology and Treatment10.1007/978-94-007-7569-5_82013157-173Analgesic Treatment of Bone MetastasesSebastiano Mercadante
Clinical Oncology10.1053/clon.2001.9223200113285Consensus Statements: Radiotherapy for Inoperable Lung Cancer, Bone Metastases, and Brain Metastases,
Clinical Oncology10.1053/clon.2001.9222200113282-84International Bone Metastases Consensus on Endpoint Measurements for Future Clinical Trials: Proceedings of the First Survey and Meeting (Work in Progress) International Bone Metastases Consensus Working Party,